Publication
Bull's Eye Maculopathy in a Patient Treated with Efavirenz
dc.contributor.author | Vaz Pereira, C | |
dc.contributor.author | Franco, M | |
dc.contributor.author | Guerra Pinto, R | |
dc.contributor.author | Lino, S | |
dc.contributor.author | Maltez, F | |
dc.contributor.author | Barrão, S | |
dc.contributor.author | Filipe, H | |
dc.date.accessioned | 2015-06-12T14:43:20Z | |
dc.date.available | 2015-06-12T14:43:20Z | |
dc.date.issued | 2014 | |
dc.description.abstract | Objective: To report a case of retinal toxicity associated with efavirenz in an adult. Methods: We describe a case of gradual-onset blurry vision in both eyes in a 37-year-old HIV Caucasian woman, on antiretroviral therapy (ART), including efavirenz. Results: The patient presented with a best corrected visual acuity of 20/100 for the right eye (RE) and 20/125 for the left eye (LE). Fundoscopy revealed mottled atrophic changes of the macular retinal pigment epithelium (RPE) in both eyes. Fluorescein angiography revealed an annular pattern of RPE atrophy in both eyes. Full-field electretinography (ERG) was normal. Conclusions: Based on our patient’s history and on previous reports, efavirenz seems to be the culprit in this case. Our report provides evidence in support of routine ophthalmological evaluation of patients on efavirenz. | por |
dc.identifier.citation | Oftalmologia. 2014 Out-Dez; 38 (4): 287-290 | por |
dc.identifier.uri | http://hdl.handle.net/10400.17/2227 | |
dc.language.iso | eng | por |
dc.peerreviewed | yes | por |
dc.publisher | Sociedade Portuguesa de Oftalmologia | por |
dc.subject | HCC INF | por |
dc.subject | HIV | por |
dc.subject | Retinal Pigment Epithelium | por |
dc.subject | Toxicity | por |
dc.title | Bull's Eye Maculopathy in a Patient Treated with Efavirenz | por |
dc.type | journal article | |
dspace.entity.type | Publication | |
oaire.citation.endPage | 290 | por |
oaire.citation.startPage | 287 | por |
oaire.citation.title | Oftalmologia | por |
rcaap.rights | openAccess | por |
rcaap.type | article | por |